Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing
Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing
This study is conducted in Japan. The aim of this observational study is to collect
 information about the safety and efficacy of Norditropin® in the long-term treatment of
 patients with a SGA (small for gestational age) short stature where the growth plate in the
 long bones (epiphyseal disc) is not closed. An extension to the GHLIQUID-1517 trial
 (NCT00184717).
Inclusion Criteria:

 -  Participation in the GHLIQUID-1517 trial

 -  Patients with SGA (small for gestational age) short stature that are still growing

 Exclusion Criteria:

 -  Known or suspected allergy to study product(s) or related products

 -  Diabetes Mellitus

 -  Patients with malignant tumor(s)

 -  Pregnant or likely to get pregnant